Tuesday, February 10, 2026 - The National Agency for Food and Drug Administration and Control (NAFDAC) has denied reports claiming it has secretly banned the antibiotic, Amoxicillin, in Nigeria.
In a public notice shared on its social media handles on
Monday, February 9, NAFDAC stated that the claim is entirely false. The agency
clarified that while it routinely issues targeted safety alerts and recalls for
specific substandard or affected batches of medicines, there is no blanket ban
on Amoxicillin.
“NAFDAC has
not banned Amoxicillin in Nigeria, either secretly or openly. As a responsible
regulatory authority, the Agency publicly notifies Nigerians of any regulatory
actions through official channels,” the statement read.
The agency emphasized that its safety communications,
including Recalls, Safety Alerts, and Blacklists, provide details on specific
product names, batch numbers, manufacturers, and necessary actions to protect
patients and healthcare providers. Blacklisting, where applicable, targets
companies for safety concerns, regulatory violations, or unethical practices
and not entire drug categories.
NAFDAC cited recent targeted alerts for specific Amoxicillin
products: In August 2025, Public Alert No. 24/2025 recalled Amoxivue 500mg
capsules due to low active pharmaceutical ingredient (API) content.
In October 2025, Public Alerts Nos. 34 and 35 addressed
substandard batches of Astamocil, Astamentin, Annmox, and Jawamox suspensions.
“These
actions were specific to identified products and do not constitute a ban on
Amoxicillin,” the agency added, urging the public, healthcare professionals,
and stakeholders to rely only on verified updates from official NAFDAC
channels.
0 Comments